|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.830 CNY | -10.03% |
|
+4.48% | -20.90% |
| 02/06 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 07/05 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 6.51B 959M 839M 773M 717M 1.36B 90.98B 1.38B 9.27B 3.6B 44.9B 3.6B 3.52B 155B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 5.37B 791M 692M 638M 591M 1.12B 75.03B 1.14B 7.65B 2.97B 37.03B 2.97B 2.9B 128B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -10.03% | ||
| 1 week | +4.48% | ||
| Current month | -1.69% | ||
| 1 month | +4.11% | ||
| 3 months | -35.08% | ||
| 6 months | -24.77% | ||
| Current year | -20.90% |
| 1 week | 5.68 |  | 6.9 |
| 1 month | 4.81 | | 6.9 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 24/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 11/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/11 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.03% | +4.48% | -21.32% | -41.47% | 881M | |
| -1.26% | +2.44% | +56.99% | +169.40% | 1,102B | |
| -0.42% | +5.09% | +71.33% | +67.33% | 643B | |
| -0.74% | +0.42% | +32.85% | +87.46% | 450B | |
| +1.34% | -2.07% | +27.62% | +22.57% | 336B | |
| -0.64% | -0.32% | +29.27% | +48.60% | 288B | |
| -2.33% | +1.91% | -27.33% | -40.30% | 222B | |
| -0.41% | +1.64% | +23.65% | +63.41% | 199B | |
| -0.41% | +8.83% | +23.44% | +81.12% | 169B | |
| +0.19% | +0.57% | -6.26% | -32.69% | 137B | |
| Average | -1.42% | +1.08% | +21.02% | +42.54% | 354.6B | |
| Weighted average by Cap. | -0.62% | +1.85% | +40.29% | +85.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.19M 85.05M 78.38M 72.65M 138M 9.22B 140M 940M 366M 4.55B 365M 357M 15.74B | 624M 91.78M 80.32M 74.02M 68.61M 130M 8.71B 132M 888M 345M 4.3B 345M 337M 14.86B |
| Net income | -74.07M -10.9M -9.54M -8.79M -8.15M -15.47M -1.03B -15.72M -105M -40.99M -511M -40.92M -40.04M -1.76B | -347M -51.1M -44.71M -41.21M -38.2M -72.51M -4.85B -73.68M -494M -192M -2.39B -192M -188M -8.27B |
| Net Debt | -1.98B -292M -255M -235M -218M -414M -27.69B -421M -2.82B -1.1B -13.66B -1.1B -1.07B -47.23B | -1.14B -168M -147M -135M -126M -238M -15.94B -242M -1.62B -632M -7.87B -631M -617M -27.19B |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | CNY 5.830 | -10.03% | 53,903,930 |
| 06/07/26 | CNY 6.480 | +1.41% | 78,545,832 |
| 03/07/26 | CNY 6.390 | -4.63% | 77,951,339 |
| 02/07/26 | CNY 6.700 | +6.69% | 95,813,037 |
| 01/07/26 | CNY 6.280 | +5.90% | 82,314,246 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
